[go: up one dir, main page]

PL2162020T3 - Środek odżywczy z nieżywotnymi bifidobakteriami i niestrawnym oligosacharydem - Google Patents

Środek odżywczy z nieżywotnymi bifidobakteriami i niestrawnym oligosacharydem

Info

Publication number
PL2162020T3
PL2162020T3 PL08766799T PL08766799T PL2162020T3 PL 2162020 T3 PL2162020 T3 PL 2162020T3 PL 08766799 T PL08766799 T PL 08766799T PL 08766799 T PL08766799 T PL 08766799T PL 2162020 T3 PL2162020 T3 PL 2162020T3
Authority
PL
Poland
Prior art keywords
nutrition
digestible oligosaccharide
viable bifidobacterium
bifidobacterium
viable
Prior art date
Application number
PL08766799T
Other languages
English (en)
Polish (pl)
Inventor
Sander Hougee
Adrianus Johannes Maria Vriesema
Johan Garssen
Jan Knol
Original Assignee
Nutricia Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutricia Nv filed Critical Nutricia Nv
Publication of PL2162020T3 publication Critical patent/PL2162020T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/22—Comminuted fibrous parts of plants, e.g. bagasse or pulp
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/733—Fructosans, e.g. inulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/519—Breve
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pediatric Medicine (AREA)
  • Pulmonology (AREA)
  • Botany (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL08766799T 2007-06-15 2008-06-13 Środek odżywczy z nieżywotnymi bifidobakteriami i niestrawnym oligosacharydem PL2162020T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/NL2007/050290 WO2008153377A1 (fr) 2007-06-15 2007-06-15 Nutrition avec une bifidobactérie non viable et un oligosaccharide non digestible
PCT/NL2008/050376 WO2008153391A2 (fr) 2007-06-15 2008-06-13 Nutrition avec une bifidobactérie non viable et un oligosaccharide non digérable
EP08766799.4A EP2162020B1 (fr) 2007-06-15 2008-06-13 Nutrition avec une bifidobactérie non viable et un oligosaccharide non digérable

Publications (1)

Publication Number Publication Date
PL2162020T3 true PL2162020T3 (pl) 2019-04-30

Family

ID=39363590

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08766799T PL2162020T3 (pl) 2007-06-15 2008-06-13 Środek odżywczy z nieżywotnymi bifidobakteriami i niestrawnym oligosacharydem

Country Status (18)

Country Link
US (2) US9456629B2 (fr)
EP (2) EP3491938A1 (fr)
CN (2) CN101801220A (fr)
AR (1) AR067020A1 (fr)
AU (1) AU2008262670B2 (fr)
BR (1) BRPI0813391B1 (fr)
CA (1) CA2691563C (fr)
CY (1) CY1121400T1 (fr)
ES (1) ES2706606T3 (fr)
HR (1) HRP20190180T1 (fr)
HU (1) HUE042392T2 (fr)
MY (1) MY162245A (fr)
NZ (1) NZ582264A (fr)
PL (1) PL2162020T3 (fr)
RU (1) RU2475051C2 (fr)
TR (1) TR201901325T4 (fr)
UA (1) UA100985C2 (fr)
WO (2) WO2008153377A1 (fr)

Families Citing this family (94)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006012536A2 (fr) 2004-07-22 2006-02-02 Ritter Andrew J Procedes et compositions pour le traitement de l'intolerance au lactose
WO2008153377A1 (fr) * 2007-06-15 2008-12-18 N.V. Nutricia Nutrition avec une bifidobactérie non viable et un oligosaccharide non digestible
EP2217253B1 (fr) * 2007-12-07 2011-06-29 N.V. Nutricia Bifidobactérie pour une allergie contre les acariens détriticoles
US20110117077A1 (en) * 2008-06-13 2011-05-19 N.V. Nutricia Nutritional composition for infants delivered via caesarean section
EP2452574A1 (fr) * 2010-11-15 2012-05-16 Nestec S.A. Formule de nutrition personnalisée en fonction de l'âge avec une densité calorique adaptée particulièrement aux jeunes enfants
BRPI0923171A2 (pt) * 2008-12-19 2015-08-11 Nestec Sa Prevenção e tratamento da diarréia causada por rotavírus.
CA2752800C (fr) 2009-02-24 2017-12-05 Ritter Pharmaceuticals, Inc. Formulations prebiotiques et methodes d'utilisation
CA2760999A1 (fr) † 2009-03-13 2010-09-16 Mariana Barboza Oligosaccharides prebiotiques
ES2382263T3 (es) * 2009-05-11 2012-06-06 Nestec S.A. Prevención y tratamiento de la diarrea alérgica
EP2251020A1 (fr) * 2009-05-11 2010-11-17 Nestec S.A. Traitement haute température de courte durée qui génère des préparations microbiennes avec des profils anti-inflammatoires
JP5860396B2 (ja) * 2009-05-11 2016-02-16 ネステク ソシエテ アノニム ラクトバチルス・ジョンソニーＬａ１ＮＣＣ５３３（ＣＮＣＭＩ−１２２５）及び免疫障害
EP2251022A1 (fr) * 2009-05-11 2010-11-17 Nestec S.A. Micro-organismes sans réplication, et leur effet d'augmentation immunitaire
ITMI20091034A1 (it) * 2009-06-11 2010-12-12 Parmalat Spa Specie probiotica di bifidobacterium breve
PT2467032T (pt) * 2009-08-18 2018-04-04 Nestec Sa Composição nutricional compreendendo estirpes de bifidobacterium longum e que reduz os sintomas de alergia alimentar, especialmente em lactentes e crianças
WO2011020853A1 (fr) * 2009-08-18 2011-02-24 Cosucra-Groupe Warcoing Sa Compositions contenant des mélanges de fibres fermentescibles
EP2308498A1 (fr) * 2009-09-30 2011-04-13 Nestec S.A. Administration de bifidobacterium rapide au cours de l'enfance pour empêcher une inflammation postérieure au cours de la vie
IT1398553B1 (it) * 2010-03-08 2013-03-01 Probiotical Spa Composizione comprendente batteri probiotici per il trattamento di patologie associate con le alterazioni del sistema immunitario.
WO2011137249A1 (fr) 2010-04-28 2011-11-03 Ritter Pharmaceuticals, Inc. Formulations prébiotiques et méthodes d'utilisation
WO2011149336A1 (fr) * 2010-05-25 2011-12-01 N.V. Nutricia Composition nutritionnelle d'empreinte immunitaire
WO2011149335A1 (fr) 2010-05-25 2011-12-01 N.V. Nutricia Composition nutritionnelle d'empreinte immunitaire
EP3097791B1 (fr) * 2010-06-04 2018-05-16 N.V. Nutricia Oligosaccharides non digestibles pour l'induction de tolérance orale contre des protéines alimentaires
WO2011150949A1 (fr) * 2010-06-04 2011-12-08 N.V. Nutricia Oligosaccharides non digestibles pour l'induction d'une tolérance orale contre des protéines alimentaires
EP2449890A1 (fr) * 2010-11-05 2012-05-09 Nestec S.A. Compositions de céréale en poudre comprenant des micro-organismes probiotiques sans réplication
EP2455094A1 (fr) * 2010-11-11 2012-05-23 Nestec S.A. Micro-organismes probiotiques sans réplication pour protéger les enfants contre les infections gastro-intestinales
EP2452573A1 (fr) * 2010-11-15 2012-05-16 Nestec S.A. Composition nutritionnelle personnalisée en fonction de l'âge avec graisse animale et graisse végétale
EP2454948A1 (fr) * 2010-11-23 2012-05-23 Nestec S.A. Mélange oligosaccharide et produit alimentaire comportant ce mélange, spécialement une formule pour enfants
RU2600877C2 (ru) * 2010-12-06 2016-10-27 Н.В. Нютрисиа Ферментированное детское питание
SG191799A1 (en) 2010-12-31 2013-08-30 Abbott Lab Nutritional formulations including human milk oligosaccharides and long chain polyunsaturated polyunsaturated fatty acids and uses thereof
CA2822497C (fr) 2010-12-31 2020-07-28 Abbott Laboratories Procedes de reduction de l'incidence du stress oxydatif utilisant des oligosaccharides du lait de femme, de la vitamine c et des agents anti-inflammatoires
MX376863B (es) 2010-12-31 2025-03-07 Abbott Lab Metodos para disminuir la incidencia de la enterocolitis necrotizante en bebes, infantes, o niños al usar los oligosacaridos de leche humana.
CN109620834A (zh) 2010-12-31 2019-04-16 雅培制药有限公司 使用人乳寡糖改善呼吸道健康的方法
ES2719404T5 (es) 2010-12-31 2024-09-18 Abbott Lab Composiciones nutricionales que comprenden oligosacáridos de leche humana para el uso en el tratamiento y/o prevención de la infección por rotavirus entérico
CA3205169A1 (fr) 2010-12-31 2012-07-05 Abbott Laboratories Oligosaccharides de lait humain pour moduler l' inflammation
EP2658401A2 (fr) * 2010-12-31 2013-11-06 Abbott Laboratories Oligosaccharides de lait humain pour favoriser la croissance de bactéries bénéfiques
IT1403661B1 (it) 2011-01-28 2013-10-31 Probiotical Spa Composizione effervescente in forma solida per uso in applicazioni vaginali per il trattamento di infezioni vaginali.
MX2013008500A (es) 2011-02-04 2014-03-05 Univ California Disialillacto-n-tetraosa (dslnt) o variantes, isomeros, analogos y derivados de la misma para prevenir o inhibir la enfermedad del intestino.
ITMI20110791A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri in grado di metabolizzare gli ossalati.
ITMI20110792A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri appartenenti al genere bifidobacterium per uso nel trattamento della ipercolesterolemia.
ITMI20110793A1 (it) * 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri probiotici e composizione sinbiotica contenente gli stessi destinata alla alimentazione dei neonati.
DK2734049T3 (en) 2011-06-20 2018-07-30 Heinz Co Brands H J Llc PROBIOTIC COMPOSITIONS AND PROCEDURES
WO2012177118A1 (fr) 2011-06-22 2012-12-27 N.V. Nutricia Méthode permettant de limiter la survenue d'infections chez le jeune enfant
PH12014500024A1 (en) * 2011-07-12 2020-12-18 Nestec Sa Probiotic for administration to healthy young mammals during the weaning period for improving tolerance to newly introduced food stuffs
GB201112091D0 (en) 2011-07-14 2011-08-31 Gt Biolog Ltd Bacterial strains isolated from pigs
US10639319B2 (en) 2011-08-29 2020-05-05 Abbott Laboratories Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
ITRM20110477A1 (it) 2011-09-09 2013-03-10 Giovanni Mogna Composizione comprendente n-acetilcisteina e/o lisozima microincapsulato gastroprotetto in associazione con batteri probiotici in grado di ripristinare l'effetto barriera proprio dello stomaco che viene perso durante il trattamento farmacologico dell
ITMI20111718A1 (it) 2011-09-23 2013-03-24 Probiotical Spa Un materiale impermeabile alla umidita e allo ossigeno per confezionare prodotti dietetici, cosmetici e specialita medicinali.
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
WO2013057072A1 (fr) * 2011-10-18 2013-04-25 Nestec S.A. Composition destinée à être utilisée pour favoriser l'absorption de magnésium et/ou la rétention de magnésium
RU2014119930A (ru) * 2011-10-18 2015-11-27 Нестек С.А. Композиция, предназначенная для применения в стимулировании здорового костного роста и/или в профилактике, и/или терапии заболеваний кости
EP2770854A1 (fr) * 2011-10-24 2014-09-03 N.V. Nutricia Traitement contre les allergies comprenant un oligosaccharide non digestible
WO2013187755A1 (fr) * 2012-06-14 2013-12-19 N.V. Nutricia Formule fermentée avec oligosaccharides non digestibles pour nourrissons
PL2914136T3 (pl) * 2012-11-02 2021-11-29 N.V. Nutricia Połączenie synbiotyków do poprawy czynności mózgu
CA2891947A1 (fr) * 2012-11-29 2014-06-05 Nestec S.A. Composition symbiotique et son utilisation
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
US9980991B2 (en) 2013-05-10 2018-05-29 H.J. Heinz Company Brands Llc Probiotics and methods of use
ITMI20130793A1 (it) 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle cistiti ricorrenti.
EP3079502A1 (fr) * 2013-11-04 2016-10-19 N.V. Nutricia Préparation fermentée avec des oligosaccharides non digestibles
US20160303226A1 (en) * 2013-11-25 2016-10-20 Nestec S.A. Heat-treated formulation of bifidobacterium lactis ncc 2818 reduces allergic manifestations
WO2016053085A1 (fr) 2014-09-30 2016-04-07 N.V. Nutricia Composition comprenant une source d'uridine et des fibres produisant du butyrate, utilisable en vue de la prévention de troubles gastro-intestinaux
EP3209308B1 (fr) * 2014-10-24 2022-08-03 Evolve Biosystems Inc. Bifidobactéries activées et leurs méthodes d'utilisation
US10609475B2 (en) 2014-12-05 2020-03-31 Stages Llc Active noise control and customized audio system
WO2016102950A1 (fr) 2014-12-23 2016-06-30 4D Pharma Research Limited Immunomodulation
HRP20180847T1 (hr) 2014-12-23 2018-08-24 4D Pharma Research Limited Pirinski polipeptid i imunološka modulacija
US10821124B2 (en) 2015-03-05 2020-11-03 Societe Des Produits Nestle S.A. Compositions for use in improving stool consistency or frequency in infants or young children
MA41060B1 (fr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
EP3662917A1 (fr) 2015-06-15 2020-06-10 4D Pharma Research Limited Compositions comprenant des souches bactériennes
MA41010B1 (fr) 2015-06-15 2020-01-31 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
PL3650033T3 (pl) 2015-06-15 2022-05-16 4D Pharma Research Limited Kompozycje zawierające szczepy bakteryjne
RS59446B1 (sr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Blautia stercosis i wexlerae za upotrebu u lečenju inflamatornih i autoimunskih bolesti
WO2017043962A1 (fr) * 2015-09-11 2017-03-16 N.V. Nutricia Procédé de stimulation de la santé du microbiote après une naissance non naturelle
PL3209310T3 (pl) 2015-11-20 2018-08-31 4D Pharma Research Limited Kompozycja zawierająca szczepy bakteryjne
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520631D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520638D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
EP3397075A1 (fr) * 2015-12-29 2018-11-07 N.V. Nutricia Formule nutritionnelle à base d'oligosaccharides non digestibles et de bactéries non réplicatives produisant de l'acide lactique
MD3313423T2 (ro) 2016-03-04 2019-10-31 4D Pharma Plc Compoziții care conțin tulpini bacteriene de Blautia pentru tratamentul hipersensibilității viscerale
GB201612191D0 (en) 2016-07-13 2016-08-24 4D Pharma Plc Compositions comprising bacterial strains
MA45334A (fr) 2016-03-24 2019-01-30 Probiotical Spa Composition bactérienne d'acide lactique pour le traitement d'infections vaginales bactériennes par gardnerella vaginalis et, éventuellement, d'infections fongiques concurrentes
AU2017275210B2 (en) * 2016-05-31 2020-09-10 Morinaga Milk Industry Co., Ltd. Brain function improving agent
TWI802545B (zh) 2016-07-13 2023-05-21 英商４Ｄ製藥有限公司 包含細菌菌株之組合物
GB201621123D0 (en) 2016-12-12 2017-01-25 4D Pharma Plc Compositions comprising bacterial strains
CA3064171A1 (fr) 2017-05-22 2018-11-29 4D Pharma Research Limited Compositions comprenant des souches bacteriennes
WO2018215782A1 (fr) 2017-05-24 2018-11-29 4D Pharma Research Limited Compositions comprenant des souches bactériennes
MA49373B1 (fr) 2017-06-14 2021-02-26 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
HRP20201629T1 (hr) 2017-06-14 2020-12-25 4D Pharma Research Limited Sastavi koji sadrže bakterijski soj roda megasphaera i njihove upotrebe
JP6840272B2 (ja) 2017-06-14 2021-03-10 フォーディー ファーマ リサーチ リミテッド４Ｄ Ｐｈａｒｍａ Ｒｅｓｅａｒｃｈ Ｌｉｍｉｔｅｄ 細菌株を含む組成物
BR112019028039A2 (pt) * 2017-06-30 2020-07-07 N.V. Nutricia composição nutricional, uso de uma combinação de bifidobacterium breve e oligossacarídeos não digeríveis, e método para prevenir e/ou reduzir o risco de ocorrência de hiperinsulinemia
BR112019028006A2 (pt) * 2017-06-30 2020-07-07 N.V. Nutricia composição nutricional, uso de uma combinação de bifidobacterium breve e oligossacarídeos não digeríveis, e método para prevenir e/ou reduzir o risco de ocorrência de hipercolesterolemia e/ou aterosclerose
JP7152472B2 (ja) * 2018-03-23 2022-10-12 森永乳業株式会社 Ｆｇｆ２１分泌促進用組成物
TW202023590A (zh) * 2018-08-17 2020-07-01 英商4D製藥研究有限公司 包含細菌菌株之組合物
US20240307338A1 (en) * 2021-01-27 2024-09-19 Sichuan Jiuzhang Biological Science And Technology Co., Ltd. Use of pharmaceutical composition containing chlorogenic acid in preparation of medicament for treating pathologic jaundice
CN114767720A (zh) * 2022-05-12 2022-07-22 上海交通大学医学院附属瑞金医院 一种短双歧杆菌m-16v在制备药物中的应用
CN114949006A (zh) * 2022-06-10 2022-08-30 上海交通大学医学院附属瑞金医院 一种短双歧杆菌m-16v在制备缓解卵清蛋白诱导的食物过敏药物中的应用
EP4574160A1 (fr) * 2023-12-20 2025-06-25 Hipp & Co Composition comprenant une souche de bifidobacterium breve pour son utilisation dans la prevention des allergies cutanées

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2617758B2 (ja) * 1988-03-25 1997-06-04 株式会社ヤクルト本社 抗体産生増強型免疫賦活剤
US5602109A (en) * 1994-01-10 1997-02-11 Abbott Laboratories Method to enhance the immune system of a human
US6645506B1 (en) 1997-04-18 2003-11-11 Ganeden Biotech, Inc. Topical compositions containing extracellular products of Pseudomonas lindbergii and Emu oil
DE19836339B4 (de) * 1998-08-11 2011-12-22 N.V. Nutricia Kohlenhydratmischung
US6077558A (en) * 1998-12-23 2000-06-20 Bristol-Myers Squibb Company Elemental nutritional products
ATE270558T1 (de) * 1999-08-26 2004-07-15 Ganeden Biotech Inc Verwendung von emu-öl als träger für fungizide, antibakterielle und antivirale arzneien
FI109602B (fi) * 2001-01-25 2002-09-13 Valio Oy Probioottiyhdistelmä
US20030157067A1 (en) * 2002-02-19 2003-08-21 Bartels Jennifer F. Formulation and method for preventing antibiotics-induced diaper rash
EP1638416B1 (fr) * 2003-06-23 2013-05-01 Nestec S.A. Utilisation d'une formule nutritionnelle pour fonction de barriere intestinale optimale
DK1675481T3 (da) * 2003-10-24 2009-01-19 Nutricia Nv Synbiotisk præparat til börn
US20090257993A1 (en) * 2003-12-17 2009-10-15 M Rabet Laura Lactic Acid Producing Bacteria and Lung Function
US8252769B2 (en) * 2004-06-22 2012-08-28 N. V. Nutricia Intestinal barrier integrity
DE602004006258T3 (de) * 2004-08-24 2013-08-29 Nutricia N.V. Nahrungszusammensetzung die unverdauliche Transgalaktooligosaccharide sowie verdauliche Galaktose-Saccharide enthält
US20060194241A1 (en) * 2005-02-28 2006-08-31 Jan Knol Lactobacillus specific probes
BRPI0608782A2 (pt) * 2005-04-13 2010-01-26 Nestec Sa fórmula para bebê com probióticos
WO2006115412A2 (fr) 2005-04-27 2006-11-02 N.V. Nutricia Nutrition avec des lipides et des saccharides non digestibles
EP1776877A1 (fr) * 2005-10-21 2007-04-25 N.V. Nutricia Méthode de stimulation de la flore intestinale
WO2008153377A1 (fr) * 2007-06-15 2008-12-18 N.V. Nutricia Nutrition avec une bifidobactérie non viable et un oligosaccharide non digestible

Also Published As

Publication number Publication date
CN101801220A (zh) 2010-08-11
UA100985C2 (ru) 2013-02-25
CN105639631A (zh) 2016-06-08
CA2691563C (fr) 2016-08-02
WO2008153391A3 (fr) 2009-02-05
ES2706606T3 (es) 2019-03-29
CA2691563A1 (fr) 2008-12-18
US9456629B2 (en) 2016-10-04
US20100278781A1 (en) 2010-11-04
RU2010101056A (ru) 2011-07-20
WO2008153377A1 (fr) 2008-12-18
HRP20190180T1 (hr) 2019-03-22
AU2008262670A1 (en) 2008-12-18
AU2008262670B2 (en) 2014-02-13
MY162245A (en) 2017-05-31
US9883692B2 (en) 2018-02-06
WO2008153391A2 (fr) 2008-12-18
NZ582264A (en) 2012-03-30
EP3491938A1 (fr) 2019-06-05
HUE042392T2 (hu) 2019-06-28
EP2162020A2 (fr) 2010-03-17
TR201901325T4 (tr) 2019-02-21
BRPI0813391B1 (pt) 2018-12-11
RU2475051C2 (ru) 2013-02-20
BRPI0813391A2 (pt) 2014-12-30
AR067020A1 (es) 2009-09-30
EP2162020B1 (fr) 2018-10-31
CY1121400T1 (el) 2020-05-29
US20170049143A1 (en) 2017-02-23

Similar Documents

Publication Publication Date Title
HRP20190180T1 (hr) Hrana s nevijabilnom bifidobakterijom i neprobavljivim oligosaharidom
ZA200808635B (en) Food supplements and uses thereof
PL2134833T3 (pl) Probiotyczny szczep Bifidobacterium
GB2460781B (en) Probiotic bifidobacterium strains
EP2185692A4 (fr) Hco32 et hco27 et exemples connexes
IL198567A0 (en) Carbohydrate specific cellular immunity inducing microorganisms and uses thereof
ZA200809060B (en) High-calorie nutritional supplement
ZA201202155B (en) Bifidobacterium longum and functional gi disorders
EP2161013A4 (fr) Connecteur femelle et connecteur
IL215998A (en) Gut connectors and systems
SG10201402793PA (en) Sugar chain-related gene and use thereof
PL2258219T3 (pl) Żywienie za pomocą lipidów i niestrawnych sacharydów
EP2129934A4 (fr) Boîte de transfert à surmultipliée
GB0808575D0 (en) Compilign and linking
PL2169118T3 (pl) Konstrukcja naziemna z elementami łączącymi
ZA201006795B (en) Novel opaque modifiers in corn and related methods
EP2175947A4 (fr) Dispositif en relation avec de petits articles
IL193921A0 (en) Maduramicin compositions and methods
EP2146583A4 (fr) Lait glyqué et utilisations de celui-ci
ZA201000357B (en) 2-Azetidinemethaneamines and 2-pyrrolidinemethaneamines as Taar-Ligands
PL2040723T3 (pl) Bakteria kwasu mlekowego o podwyższonej tolerancji na kwas
GB0718162D0 (en) Nilbac bacterial control in fuels and other liquids
EP2185685A4 (fr) Nouveaux procédés et nouvelles lignées cellulaires
GB0720970D0 (en) Food additives - sclerenchyma and sclereids
GB0718462D0 (en) Methods and products